Table 4.
Number of glaucoma medications used in patients undergoing selective laser trabeculoplasty
Number of medications
|
Baseline
|
1 d
|
1 wk
|
1 mo
|
3 mo
|
6 mo
|
12 mo
|
36 mo
|
OAG | 3.39 ± 0.69 | 3.31 ± 0.82 | 2.75 ± 0.5 | 2.06 ± 0.79 | 2.19 ± 0.71 | 2.39 ± 0.64 | 2.34 ± 0.64 | 2.5 ± 0.69 |
P1 value | 0.083 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | |
PGS | 2.97 ± 0.74 | 2.85 ± 0.67 | 2.51 ± 0.56 | 1.33 ± 1.28 | 1.44 ± 1.23 | 1.77 ± 0.99 | 1.79 ± 1.02 | 1.9 ± 0.82 |
P1 value | 0.025 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | |
P2 value | 0.015 | 0.005 | 0.048 | 0.004 | 0.003 | 0.006 | 0.008 | 0.007 |
OAG: Open angle glaucoma; PGS: Prior glaucoma surgery. P1: Wilcoxon signed rank test, difference of medication quantity between selective laser trabeculoplasty treatment and baseline group at different time points. P2: Mann-Whitney test, Comparison within groups, difference of medication quantity between open angle glaucoma and prior glaucoma surgery group at different time points.